Mestag Therapeutics

Mestag Therapeutics, founded in 2020, aims to develop effective new drugs for patients with inflammation and cancer. Recent data indicates that a type of cell called fibroblasts plays a significant driving role in disease progression.The mission is to take a leadership role in the discovery, development, and delivery of impactful precision medicines through unparalleled insights into disease-driving subsets of fibroblasts.